In an exciting new study completed in the UK researchers showed that the right kind of Modified Citrus Pectin (MCP) can stop deadly kidney fibrosis in it’s tracks.
The MCP accomplishes this by binding to and blocking a certain protein molecule called galectin-3. By disabling the galectin-3 molecules, MCP decreased the effects of inflammation and fibrosis in a kidney injury model.
It’s now understood that unhealthy levels of galectin-3 molecules are tied to the progression of a number of serious diseases including, of course, heart disease and cancer. And this new research out of the UK opens up some exciting new uses for MCP.
In this new pre-clinical study, scientists at the Nephro-Urology Dept. of UCL Institute of Child Health in London, UK, researched the effects of a unique form of Modified Citrus Pectin in induced kidney fibrosis disease.
The findings demonstrate the potential of using Modified Citrus Pectin as a new compound for acute kidney injury and its potential role in protection from other inflammatory and fibrosis related conditions. .
Because this citrus pectin is modified to a specific low molecular weight range and structure, it can easily be absorbed into the circulation and reach specific organs and tissues affected by this dangerous inflammation and fibrosis process.
Now that we understand more about the role of galectin-3 in inflammation and fibrosis, we can use Modified Citrus Pectin to target various conditions involved in abnormal cellular growth and fibrosis, as well as apply it for preventative purposes. .
Modified Citrus Pectin: Successfully Treating the “Untreatable”
Fibrosis is responsible for many chronic and deadly disease states because of the overproduction of excessive scar tissue within various organs and systems.
Conditions such as
- cardiovascular & heart disease
- pulmonary fibrosis (lung disease)
- cirrhosis of the liver
- kidney disease
- and many other serious health problems
involve inflammation and fibrosis.
By binding to the galectin-3 molecules, Modified Citrus Pectin prevents galectin-3 from fostering harmful inflammation, excessive scar tissue build up and abnormal cellular growth.
This new discovery shows MCP has enormous potential for prevention and treatment of inflammation and fibrosis related conditions for which there are currently limited or no treatments available.
As a pioneer in the field of Modified Citrus Pectin research, I want to emphasize that this new research is truly exciting because Modified Citrus Pectin is turning out to be much, much, more versatile than anyone imagined. .
Getting Answers With A FDA Approved Galectin-3 Blood Test
A new blood test, which measures circulating levels of galectin-3, has been approved by the FDA and most health insurance as a useful tool in helping to determine cardiovascular disease risk and prognosis, as well as risks of cancer metastasis. The development and use of this simple blood test by conventional medicine means that galectin-3 is now on its way to being widely accepted and used as a therapeutic target in conditions from congestive heart failure to metastatic cancer and more.
And Modified Citrus Pectin remains the leading natural galectin-3 inhibitor able to get into the blood stream and bind to galectin-3 throughout the body. .
As more research continues on the role of galectin-3 in a wide range of diseases, the extreme usefulness of Modified Citrus Pectin will continue to grow as well, offering new hope to patients seeking safe and effective therapies for fighting disease and restoring health naturally.
For more information about the history and uses of Modified Citrus Pectin, please visit my Research Library.
Kolatsi-Joannou M, Price KL, Winyard PJ, Long DA. Modified Citrus Pectin Reduces Galectin-3 Expression and Disease Severity in Experimental Acute Kidney Injury. PLoS ONE 2011 April 6(4): e18683. doi:10.1371/journal.pone.0018683.
Dr. Isaac Eliaz, a pioneer in the field of integrative medicine since the early 1980's, is a respected author, lecturer, researcher, product formulator and clinical practitioner.
Since 1991 Dr. Eliaz has maintained a busy private practice in northern California that focuses primarily on integrative, holistic protocols for cancer patients. He leads an integrative medical team at Amitabha Clinic in Sebastopol, California with focus on cancer and other chronic ailments.
To learn more, please visit www.dreliaz.org.
Latest posts by Dr. Isaac Eliaz (see all)
- Trouble sleeping? Top tips for a great night’s sleep - June 7, 2016
- 4 ancient medicinal mushrooms fight modern diseases - June 2, 2016
- Ancient wisdom meets modern science in the fight against cancer - March 15, 2016